Skip to main content
. 2009 Nov 5;4(11):e7638. doi: 10.1371/journal.pone.0007638

Figure 1. MRZR in patients with CIS.

Figure 1

Figure shows biomarkers that help to evaluate the risk of multiple sclerosis in patients with clinically isolated syndrome (CIS). MRI  =  lesion load in T2-weighted magnetic resonance imaging (lesions >3 mm2), OCB  =  oligoclonal bands in cerebrospinal fluid (CSF), MRZR  =  MRZ reaction, antibodies to measles, rubella and varicella zoster virus in CSF with two or more AI (antibody indices) ≥1.5. RRMS  =  relapsing-remitting multiple sclerosis.